发明名称 |
Assays for determining the effect of an immune cell on a cell from an infectious or neoplastic disease |
摘要 |
An in vitro assay is provided for determining the effect of an immune cell on a cell from an infectious or neoplastic disease. Also provided is an in vitro assay for determining the effect of an activated CD8+ T-cell on a sensitized melanoma cell. A method for improving the specific cytolytic activity (SCA) of an immune cell comprising contacting an immune cell with an antigen and an antigen-independent pro-inflammatory agent is provided. A method for ex vivo expansion of antigen-specific CD8+ T-cells with enhanced specific cytolytic activity (SCA) comprising culturing the antigen-specific CD8+ T-cells in a suitable culture media comprising an amino acid. An in vitro assay is provided for determining the effect of an immune cell on a cell from an infectious or neoplastic disease. A method of treating a subject suffering from an infectious or neoplastic disease with immuno therapy is described. |
申请公布号 |
US9488644(B2) |
申请公布日期 |
2016.11.08 |
申请号 |
US201013509405 |
申请日期 |
2010.11.11 |
申请人 |
The Trustees of Columbia University in the City of New York |
发明人 |
Silverstein Samuel C.;Loike John D.;Budhu Sadna;Lee Peter P. |
分类号 |
C12Q1/02;G01N33/50;A61K35/17;A61K38/20;A61K45/06 |
主分类号 |
C12Q1/02 |
代理机构 |
Bryan Cave LLP |
代理人 |
Bryan Cave LLP |
主权项 |
1. An in vitro assay for determining the effect of an immune cell on a cell from an infectious or neoplastic disease comprising:
(a) providing a gel comprising:
(i) collagen and fibrin, which gel is sufficient to support viability of an immune cell and growth of a cell from an infectious or neoplastic disease and(ii) an immune cell and a cell from an infectious or neoplastic disease disposed within the gel; (b) incubating the gel under conditions that support viability of the immune cell and growth of the cell from the infectious or neoplastic disease for a period of time sufficient to determine whether the immune cell has an effect on the cell from the infectious or neoplastic disease; (c) determining the number of viable cells from the infectious or neoplastic disease, if any, that are present after step (b),wherein the determining step comprises carrying out a clonogenic assay to determine how many, if any, cells from the infectious or neoplastic disease are present. |
地址 |
New York NY US |